newdrugapprovals.org
FDA Approves New Drug Application (NDA) for Teva’s Quartette (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets for the Prevention of Pregnancy
levonorgestrel ethinyl estradiol Quartette™ Represents the Next Generation of Extended Regimen Oral Contraceptives JERUSALEM 30 MAR 2013 Teva Pharmaceutical Industries Ltd. today announced that the…